The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 24, 2016
Filed:
Nov. 05, 2013
Stephan-georg Mueller, Warthausen, DE;
Christopher John Brown, Marcham, GB;
Alexander Heifetz, Didcot, GB;
Bernd Nosse, Biberach an der Riss, DE;
Juergen Prestle, Biberach an der Riss, DE;
Natacha Prevost, Sutton Courtenay, GB;
Klaus Rudolf, Warthausen, DE;
Stefan Scheuerer, Warthausen, DE;
Marcus Schindler, Nuneham Courtenay, GB;
Dirk Stenkamp, Biberach an der Riss, DE;
Leo Thomas, Biberach an der Riss, DE;
Heather Tye, East Hagbourne, GB;
Stephan-Georg Mueller, Warthausen, DE;
Christopher John Brown, Marcham, GB;
Alexander Heifetz, Didcot, GB;
Bernd Nosse, Biberach an der Riss, DE;
Juergen Prestle, Biberach an der Riss, DE;
Natacha Prevost, Sutton Courtenay, GB;
Klaus Rudolf, Warthausen, DE;
Stefan Scheuerer, Warthausen, DE;
Marcus Schindler, Nuneham Courtenay, GB;
Dirk Stenkamp, Biberach an der Riss, DE;
Leo Thomas, Biberach an der Riss, DE;
Heather Tye, East Hagbourne, GB;
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;
Abstract
The present invention relates to compounds defined by formula I wherein the groups X, Y, W and Rto Rare defined as in claim, possessing valuable pharmacological activity. Particularly the compounds are agonists of the 5-HT2C receptor, and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this receptor, such as metabolic and CNS-related disorders.